Jai-shin Liu
Hsinchu, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Nasopharyngeal carcinoma patient-derived xenograft mouse models reveal potential drugs targeting cell cycle, mTOR, and autophagy pathways.
Journal: Translational oncology
Published: July 05, 2023
Natural product myricetin is a pan-KDM4 inhibitor which with poly lactic-co-glycolic acid formulation effectively targets castration-resistant prostate cancer.
Journal: Journal of biomedical science
Published: February 20, 2022
Caffeic acid phenethyl ester suppresses androgen receptor signaling and stability via inhibition of phosphorylation on Ser81 and Ser213.
Journal: Cell communication and signaling : CCS
Published: March 09, 2019
Structure-guided design of Serratia marcescens short-chain dehydrogenase/reductase for stereoselective synthesis of (R)-phenylephrine.
Journal: Scientific reports
Published: August 22, 2017
Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening.
Journal: Oncotarget
Published: November 04, 2016
Structure and mechanism of an antibiotics-synthesizing 3-hydroxykynurenine C-methyltransferase.
Journal: Scientific reports
Published: January 13, 2015
Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis.
Journal: Molecular oncology
Published: February 24, 2014
Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1.
Journal: The Journal of biological chemistry
Published: March 29, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026